{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T02:43:41Z","timestamp":1792205021892,"version":"4.4.0"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,15]],"date-time":"2025-07-15T00:00:00Z","timestamp":1752537600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,7,15]],"date-time":"2025-07-15T00:00:00Z","timestamp":1752537600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-10048-4","type":"journal-article","created":{"date-parts":[[2025,7,15]],"date-time":"2025-07-15T22:20:15Z","timestamp":1752618015000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Facile synthesis of aminobiphenyl sulfonamides via Chan\u2013Lam coupling and their biological evaluation as potent carbonic anhydrase inhibitors"],"prefix":"10.1038","volume":"15","author":[{"given":"Moniba","family":"Sharif","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abid","family":"Mahmood","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aqsa","family":"Kanwal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matloob","family":"Ahmad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nasir","family":"Rasool","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammad Usman","family":"Qamar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammed H. AL","family":"Mughram","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amira Ali Mohammed","family":"Al-Harethi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tawaf Ali","family":"Shah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Imran Ibrahim","family":"Shaikh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,15]]},"reference":[{"key":"10048_CR1","doi-asserted-by":"crossref","unstructured":"Supuran, C. T., Scozzafava, A. & Casini, A. Carbonic anhydrase inhibitors. Med. Res. Rev. 23, 146\u2013189. https:\/\/doi.org\/110.1002\/med.10025 (2003).","DOI":"10.1002\/med.10025"},{"key":"10048_CR2","doi-asserted-by":"crossref","unstructured":"Supuran, C. T. Carbonic anhydrases: novel therapeutic applications for inhibitors and activators. Nature reviews Drug discovery 7, 168\u2013181. https:\/\/doi.org\/110.1038\/nrd2467 (2008).","DOI":"10.1038\/nrd2467"},{"key":"10048_CR3","doi-asserted-by":"crossref","unstructured":"Neri, D. & Supuran, C. T. Interfering with pH regulation in tumours as a therapeutic strategy. Nature reviews Drug discovery 10, 767\u2013777. https:\/\/doi.org\/710.1038\/nrd3554 (2011).","DOI":"10.1038\/nrd3554"},{"key":"10048_CR4","doi-asserted-by":"crossref","unstructured":"Carta, F. & Supuran, C. T. Diuretics with carbonic anhydrase inhibitory action: a patent and literature review (2005\u20132013). Expert opinion on therapeutic patents 23, 681\u2013691. https:\/\/doi.org\/610.1517\/13543776.13542013.13780598 (2013).","DOI":"10.1517\/13543776.2013.780598"},{"key":"10048_CR5","doi-asserted-by":"publisher","first-page":"105920","DOI":"10.1016\/j.bioorg.2022.105920","volume":"126","author":"A Kumar","year":"2022","unstructured":"Kumar, A., Siwach, K., Supuran, C. T. & Sharma, P. K. A decade of tail-approach based design of selective as well as potent tumor associated carbonic anhydrase inhibitors. Bioorg. Chem. 126, 105920. https:\/\/doi.org\/105910.101016\/j.bioorg.102022.105920 (2022).","journal-title":"Bioorg. Chem."},{"key":"10048_CR6","doi-asserted-by":"crossref","unstructured":"Supuran, T. C. Structure and function of carbonic anhydrases. Biochem. J. 473, 2023\u20132032. https:\/\/doi.org\/2010.1042\/BCJ20160115 (2016).","DOI":"10.1042\/BCJ20160115"},{"key":"10048_CR7","doi-asserted-by":"crossref","unstructured":"Zaib, S. et al. New aminobenzenesulfonamide\u2013thiourea conjugates: synthesis and carbonic anhydrase Inhibition and Docking studies. Eur. J. Med. Chem. 78, 140\u2013150. https:\/\/doi.org\/110.1016\/j.ejmech.2014.1003.1023 (2014).","DOI":"10.1016\/j.ejmech.2014.03.023"},{"key":"10048_CR8","doi-asserted-by":"crossref","unstructured":"Aggarwal, M. & McKenna, R. Update on carbonic anhydrase inhibitors: a patent review (2008\u20132011). Expert opinion on therapeutic patents 22, 903\u2013915. https:\/\/doi.org\/910.1517\/13543776.13542012.13707646 (2012).","DOI":"10.1517\/13543776.2012.707646"},{"key":"10048_CR9","doi-asserted-by":"crossref","unstructured":"De Simone, G., Alterio, V. & Supuran, C. T. Exploiting the hydrophobic and hydrophilic binding sites for designing carbonic anhydrase inhibitors. Expert opinion on drug discovery 8, 793\u2013810. https:\/\/doi.org\/710.1517\/17460441.17462013.17795145 (2013).","DOI":"10.1517\/17460441.2013.795145"},{"key":"10048_CR10","doi-asserted-by":"crossref","unstructured":"Supuran, C. T. Carbonic anhydrases as drug targets\u2014general presentation. Drug Des. Zinc-Enzyme Inhibitors: Funct. Struct. Disease Applications, 15\u201338 (2009).","DOI":"10.1002\/9780470508169.ch2"},{"key":"10048_CR11","doi-asserted-by":"crossref","unstructured":"Supuran, C. T. & Scozzafava, A. Carbonic anhydrase inhibitors and their therapeutic potential. Expert Opinion on Therapeutic Patents 10, 575\u2013600. https:\/\/doi.org\/510.1517\/13543776.13543710.13543775.13543575 (2000).","DOI":"10.1517\/13543776.10.5.575"},{"key":"10048_CR12","doi-asserted-by":"crossref","unstructured":"Supuran, C. T. Structure-based drug discovery of carbonic anhydrase inhibitors. Journal of enzyme inhibition and medicinal chemistry 27, 759\u2013772. https:\/\/doi.org\/710.3109\/14756366.14752012.14672983 (2012).","DOI":"10.3109\/14756366.2012.672983"},{"key":"10048_CR13","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1136\/jmg.1140.1134.157","volume":"40","author":"S Liao","year":"2003","unstructured":"Liao, S. et al. Expression of cell surface transmembrane carbonic anhydrase genes CA9 and CA12 in the human eye: overexpression of CA12 (CAXII) in glaucoma. J. Med. Genet. 40, 257\u2013261. https:\/\/doi.org\/210.1136\/jmg.1140.1134.1257 (2003).","journal-title":"J. Med. Genet."},{"key":"10048_CR14","doi-asserted-by":"publisher","first-page":"115707","DOI":"10.1016\/j.ejmech.2023.115707","volume":"259","author":"S Saied","year":"2023","unstructured":"Saied, S. et al. Discovery of indolinone-bearing benzenesulfonamides as new dual carbonic anhydrase and VEGFR-2 inhibitors possessing anticancer and pro-apoptotic properties. Eur. J. Med. Chem. 259, 115707. https:\/\/doi.org\/115710.111016\/j.ejmech.112023.115707 (2023).","journal-title":"Eur. J. Med. Chem."},{"key":"10048_CR15","doi-asserted-by":"publisher","unstructured":"Pastorek, J. & Pastorekova, S. in Seminars in cancer biology. 52\u201364. https:\/\/doi.org\/10.1016\/j.semcancer.2014.1008.1002 (Elsevier).","DOI":"10.1016\/j.semcancer.2014.1008.1002"},{"key":"10048_CR16","doi-asserted-by":"crossref","unstructured":"SupuranC. T. Carbonic anhydrase inhibitors as emerging agents for the treatment and imaging of hypoxic tumors. Expert Opin. Investig. Drugs. 27, 963\u2013970. https:\/\/doi.org\/910.1080\/13543784.13542018.11548608 (2018).","DOI":"10.1080\/13543784.2018.1548608"},{"key":"10048_CR17","doi-asserted-by":"crossref","unstructured":"Supuran, T. C Experimental carbonic anhydrase inhibitors for the treatment of hypoxic tumors. J. Experimental Pharmacol. 603\u2013617. https:\/\/doi.org\/610.2147\/JEP.S265620 (2020).","DOI":"10.2147\/JEP.S265620"},{"key":"10048_CR18","doi-asserted-by":"crossref","unstructured":"Supuran, C. T. Carbonic anhydrase inhibitors. Bioorganic & medicinal chemistry letters 20, 3467\u20133474. https:\/\/doi.org\/3410.1016\/j.bmcl.3405.3009 (2010). (2010).","DOI":"10.1016\/j.bmcl.2010.05.009"},{"key":"10048_CR19","doi-asserted-by":"crossref","unstructured":"Schulze Wischeler, J. et al. Bidentate Zinc Chelators for \u03b1-Carbonic Anhydrases that Produce a Trigonal Bipyramidal Coordination Geometry. ChemMedChem 5, 1609\u20131615. https:\/\/doi.org\/1610.1002\/cmdc.201000200 (2010).","DOI":"10.1002\/cmdc.201000200"},{"key":"10048_CR20","doi-asserted-by":"publisher","first-page":"1825","DOI":"10.1016\/j.bmcl.2014.02.1015","volume":"24","author":"KM Khan","year":"2014","unstructured":"Khan, K. M. et al. Evaluation of bisindole as potent \u03b2-glucuronidase inhibitors: synthesis and in Silico based studies. Bioorg. Med. Chem. Lett. 24, 1825\u20131829. https:\/\/doi.org\/1810.1016\/j.bmcl.2014.1802.1015 (2014).","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10048_CR21","doi-asserted-by":"publisher","first-page":"61","DOI":"10.2174\/1568013013359131","volume":"1","author":"CT Supuran","year":"2001","unstructured":"Supuran, C. T. & Scozzafava, A. Carbonic anhydrase inhibitors. Curr. Med. Chemistry-Immunology Endocr. Metabolic Agents. 1, 61\u201397. https:\/\/doi.org\/10.2174\/1568013013359131 (2001).","journal-title":"Curr. Med. Chemistry-Immunology Endocr. Metabolic Agents"},{"key":"10048_CR22","doi-asserted-by":"crossref","unstructured":"Silver, L. H. & Group, T. B. P. T. S. Clinical efficacy and safety of brinzolamide (Azopt\u2122), a new topical carbonic anhydrase inhibitor for primary open-angle glaucoma and ocular hypertension. American journal of ophthalmology 126, 400\u2013408. https:\/\/doi.org\/410.1016\/S0002-9394(1098)00095-00096 (1998).","DOI":"10.1016\/S0002-9394(98)00095-6"},{"key":"10048_CR23","doi-asserted-by":"publisher","first-page":"7210","DOI":"10.1016\/j.bmc.2013.08.7033","volume":"21","author":"MA Pinard","year":"2013","unstructured":"Pinard, M. A., Boone, C. D., Rife, B. D., Supuran, C. T. & McKenna, R. Structural study of interaction between Brinzolamide and dorzolamide Inhibition of human carbonic anhydrases. Bioorg. Med. Chem. 21, 7210\u20137215. https:\/\/doi.org\/7210.1016\/j.bmc.2013.7208.7033 (2013).","journal-title":"Bioorg. Med. Chem."},{"key":"10048_CR24","doi-asserted-by":"crossref","unstructured":"Nakano, T. et al. Effects of brinzolamide, a topical carbonic anhydrase inhibitor, on corneal endothelial cells. Advances in therapy 33, 1452\u20131459. https:\/\/doi.org\/1410.1007\/s12325-12016-10373-y (2016).","DOI":"10.1007\/s12325-016-0373-y"},{"key":"10048_CR25","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1517\/1455.14559.14554.14553","volume":"9","author":"M Iester","year":"2008","unstructured":"Iester, M. Brinzolamide. Expert Opin. Pharmacother. 9, 653\u2013662. https:\/\/doi.org\/610.1517\/14656566.14656569.14656564.14656653 (2008).","journal-title":"Expert Opin. Pharmacother."},{"key":"10048_CR26","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1002\/pro.60070303","volume":"7","author":"T Stams","year":"1998","unstructured":"Stams, T. et al. Structures of murine carbonic anhydrase IV and human carbonic anhydrase II complexed with brinzolamide: molecular basis of isozyme-drug discrimination. Protein Sci. 7, 556\u2013563. https:\/\/doi.org\/510.1002\/pro.5560070303 (1998).","journal-title":"Protein Sci."},{"key":"10048_CR27","doi-asserted-by":"crossref","unstructured":"Yuan, L. et al. Carbonic anhydrase 1-mediated calcification is associated with atherosclerosis, and methazolamide alleviates its pathogenesis. Frontiers in Pharmacology 10, 766. https:\/\/doi.org\/710.3389\/fphar.00766 (2019). (2019).","DOI":"10.3389\/fphar.2019.00766"},{"key":"10048_CR28","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.nbd.2015.1011.1006","volume":"86","author":"S Fossati","year":"2016","unstructured":"Fossati, S. et al. The carbonic anhydrase inhibitor methazolamide prevents amyloid beta-induced mitochondrial dysfunction and caspase activation protecting neuronal and glial cells in vitro and in the mouse brain. Neurobiol. Dis. 86, 29\u201340. https:\/\/doi.org\/10.1016\/j.nbd.2015.1011.1006 (2016).","journal-title":"Neurobiol. Dis."},{"key":"10048_CR29","doi-asserted-by":"crossref","unstructured":"Teppema, L. J., Bijl, H., Gourabi, B. M. & Dahan, A. The carbonic anhydrase inhibitors methazolamide and acetazolamide have different effects on the hypoxic ventilatory response in the anaesthetized cat. The Journal of Physiology 574, 565\u2013572. https:\/\/doi.org\/510.1113\/jphysiol.110528 (2006). (2006).","DOI":"10.1113\/jphysiol.2006.110528"},{"key":"10048_CR30","doi-asserted-by":"crossref","unstructured":"Supuran, C. T. Indisulam: an anticancer sulfonamide in clinical development. Expert opinion on investigational drugs 12, 283\u2013287. https:\/\/doi.org\/210.1517\/13543784.13543712.13543782.13543283 (2003).","DOI":"10.1517\/13543784.12.2.283"},{"key":"10048_CR31","doi-asserted-by":"publisher","first-page":"68","DOI":"10.3390\/biomedicines11010068","volume":"11","author":"CC Mon\u00e7\u00e3o","year":"2022","unstructured":"Mon\u00e7\u00e3o, C. C. et al. Indisulam reduces viability and regulates apoptotic gene expression in pediatric high-grade glioma cells. Biomedicines 11, 68\u201383. https:\/\/doi.org\/10.3390\/biomedicines11010068 (2022).","journal-title":"Biomedicines"},{"key":"10048_CR32","doi-asserted-by":"crossref","unstructured":"de Oliveira, K. N. et al. Synthesis and antidepressant-like activity evaluation of sulphonamides and sulphonyl-hydrazones. Bioorganic & medicinal chemistry 19, 4295\u20134306. https:\/\/doi.org\/4210.1016\/j.bmc.4205.4056 (2011). (2011).","DOI":"10.1016\/j.bmc.2011.05.056"},{"key":"10048_CR33","doi-asserted-by":"crossref","unstructured":"Kurt, B. Z. et al. Synthesis, antioxidant and carbonic anhydrase I and II inhibitory activities of novel sulphonamide-substituted coumarylthiazole derivatives. Journal of enzyme inhibition and medicinal chemistry 31, 991\u2013998. https:\/\/doi.org\/910.3109\/14756366.14752015.11077823 (2016).","DOI":"10.3109\/14756366.2015.1077823"},{"key":"10048_CR34","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1371\/journal.pone.0243305","volume":"16","author":"EA Onoabedje","year":"2021","unstructured":"Onoabedje, E. A., Ibezim, A., Okoro, U. C. & Batra, S. New sulphonamide pyrolidine Carboxamide derivatives: synthesis, molecular docking, antiplasmodial and antioxidant activities. PLos One. 16, 1\u201319. https:\/\/doi.org\/10.1371\/journal.pone.0243305 (2021).","journal-title":"PLos One"},{"key":"10048_CR35","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/cbdv.202200325","volume":"19","author":"SA G\u00fcng\u00f6r","year":"2022","unstructured":"G\u00fcng\u00f6r, S. A. et al. Biological evaluation and Docking study of Mono-and Di\u2010Sulfonamide derivatives as antioxidant agents and acetylcholinesterase inhibitors. Chem. Biodivers. 19, 1\u20139. https:\/\/doi.org\/10.1002\/cbdv.202200325 (2022).","journal-title":"Chem. Biodivers."},{"key":"10048_CR36","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.bioorg.2020.104400","volume":"105","author":"SK Verma","year":"2020","unstructured":"Verma, S. K. et al. Antibacterial activities of sulfonyl or sulfonamide containing heterocyclic derivatives and its structure-activity relationships (SAR) studies: A critical review. Bioorg. Chem. 105, 1\u201314. https:\/\/doi.org\/10.1016\/j.bioorg.2020.104400 (2020).","journal-title":"Bioorg. Chem."},{"key":"10048_CR37","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/ph15030316","volume":"15","author":"A Angeli","year":"2022","unstructured":"Angeli, A. et al. Pyrazolo [4, 3-c] pyridine sulfonamides as carbonic anhydrase inhibitors: synthesis, biological and. Silico Stud. Pharmaceuticals. 15, 1\u201323. https:\/\/doi.org\/10.3390\/ph15030316 (2022).","journal-title":"Silico Stud. Pharmaceuticals"},{"key":"10048_CR38","doi-asserted-by":"crossref","unstructured":"Chen, J. Q., Li, J. H. & Dong, Z. B. A review on the latest progress of Chan-Lam coupling reaction. Advanced Synthesis & Catalysis 362, 3311\u20133331. https:\/\/doi.org\/3310.1002\/adsc.202000495 (2020).","DOI":"10.1002\/adsc.202000495"},{"key":"10048_CR39","doi-asserted-by":"publisher","first-page":"4326","DOI":"10.1021\/ol3021836","volume":"14","author":"DS Raghuvanshi","year":"2012","unstructured":"Raghuvanshi, D. S., Gupta, A. K. & Singh, K. N. Nickel-mediated N-arylation with arylboronic acids: an avenue to Chan\u2013Lam coupling. Org. Lett. 14, 4326\u20134329. https:\/\/doi.org\/4310.1021\/ol3021836 (2012).","journal-title":"Org. Lett."},{"key":"10048_CR40","doi-asserted-by":"crossref","unstructured":"Rizwan, K. et al. Copper-mediated N-arylation of methyl 2-aminothiophene-3-carboxylate with organoboron reagents. Tetrahedron letters 56, 6839\u20136842. https:\/\/doi.org\/6810.1016\/j.tetlet.6810.6080 (2015). (2015).","DOI":"10.1016\/j.tetlet.2015.10.080"},{"key":"10048_CR41","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1080\/00397911.0039014.00961196","volume":"45","author":"AA Farahat","year":"2015","unstructured":"Farahat, A. A. & Boykin, D. W. Copper (I) 3-methylsalicylate mediates the Chan\u2013Lam N-arylation of heterocycles. Synth. Commun. 45, 245\u2013252. https:\/\/doi.org\/210.1080\/00397911.00392014.00961196 (2015).","journal-title":"Synth. Commun."},{"key":"10048_CR42","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/0022-1759(1083)90303-90304","volume":"65","author":"T Mosmann","year":"1983","unstructured":"Mosmann, T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J. Immunol. Methods. 65, 55\u201363. https:\/\/doi.org\/10.1016\/0022-1759(1083)90303-90304 (1983).","journal-title":"J. Immunol. Methods"},{"key":"10048_CR43","doi-asserted-by":"publisher","first-page":"47251","DOI":"10.41021\/acsomega.52c06513","volume":"7","author":"Z Hussain","year":"2022","unstructured":"Hussain, Z. et al. Synthesis and evaluation of amide and thiourea derivatives as carbonic anhydrase (CA) inhibitors. ACS Omega. 7, 47251\u201347264. https:\/\/doi.org\/47210.41021\/acsomega.47252c06513 (2022).","journal-title":"ACS Omega"},{"key":"10048_CR44","doi-asserted-by":"publisher","first-page":"42717","DOI":"10.41038\/srep17","volume":"7","author":"A Daina","year":"2017","unstructured":"Daina, A., Michielin, O. & Zoete, V. SwissADME: a free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules. Sci. Rep. 7, 42717. https:\/\/doi.org\/42710.41038\/srep42717 (2017).","journal-title":"Sci. Rep."},{"key":"10048_CR45","doi-asserted-by":"publisher","first-page":"4540","DOI":"10.1021\/acs.orglett.49b01434","volume":"21","author":"RP Wexler","year":"2019","unstructured":"Wexler, R. P., Nuhant, P., Senter, T. J. & Gale-Day, Z. J. Electrochemically enabled chan\u2013lam couplings of Aryl boronic acids and anilines. Org. Lett. 21, 4540\u20134543. https:\/\/doi.org\/4510.1021\/acs.orglett.4549b01434 (2019).","journal-title":"Org. Lett."},{"key":"10048_CR46","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1016\/j.tetlet.2013.1011.1084","volume":"55","author":"S Battula","year":"2014","unstructured":"Battula, S., Subbareddy, G. & Chakravarthy, I. A mild and efficient copper-catalyzed N-arylation of unprotected sulfonimidamides using boronic acids. Tetrahedron Lett. 55, 517\u2013520. https:\/\/doi.org\/510.1016\/j.tetlet.2013.1011.1084 (2014).","journal-title":"Tetrahedron Lett."},{"key":"10048_CR47","doi-asserted-by":"crossref","unstructured":"Morris, G. M. et al. AutoDock4 and AutoDockTools4: Automated docking with selective receptor flexibility. Journal of computational chemistry 30, 2785\u20132791. https:\/\/doi.org\/2710.1002\/jcc.21256 (2009).","DOI":"10.1002\/jcc.21256"},{"key":"10048_CR48","unstructured":"Biovia, D. S. Discovery studio visualizer. San Diego CA USA 936, 240\u2013249 (2017)."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-10048-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-10048-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-10048-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,7]],"date-time":"2025-09-07T11:34:37Z","timestamp":1757244877000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-10048-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,15]]},"references-count":48,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["10048"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-10048-4","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,15]]},"assertion":[{"value":"21 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 August 2025","order":4,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Update","order":5,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The original online version of this Article was revised: The Acknowledgements, as well as the Funding section in the original version of this Article contained an error, where the grant number was erroneously given as \u201c(RGP2\/376\/45)\u201d. The correct grant number is \u201c(RGP2\/329\/46)\u201d for the Acknowledgements and for the Funding section, respectively. The original article has been corrected.","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"25661"}}